-+ 0.00%
-+ 0.00%
-+ 0.00%

MODERNA RECEIVES U.S. FDA APPROVAL FOR RSV VACCINE, MRESVIA, IN ADULTS AGED 18–59 AT INCREASED RISK FOR RSV DISEASE

Reuters·06/12/2025 23:26:19

Please log in to view news